TESAMORELIN Peptide – User Manual & Dosage Protocol Guide

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog designed to stimulate endogenous growth hormone (GH) secretion.

Research Applications:

• Supporting body composition studies, particularly fat metabolism
• Enhancing lean muscle mass in experimental settings
• Promoting cellular regeneration and recovery
• Investigating GH-dependent metabolic effects

Disclaimer: Tesamorelin is for research and experimental use only. It is not FDA-approved for non-research purposes. Consult a qualified healthcare professional before use.

Lyophilized Powder – Freeze-dried Tesamorelin for reconstitution

Injection Solution – Subcutaneous (SC) solution after reconstitution

Pre-filled Pens – Ready-to-use injection (research use only)

Tesamorelin functions by:

• Stimulating pituitary GHRH receptors
• Increasing pulsatile growth hormone (GH) release
• Promoting IGF-1 production, influencing anabolic and metabolic processes
• Supporting fat metabolism and muscle preservation

Effects are primarily observed in preclinical and research protocols.

Administration

Subcutaneous (SC) Injection – Typical Dose: 1–2 mg | Frequency: Once daily | Notes: Preferably administered at night to mimic natural GH rhythm

Pre-filled Pens – Typical Dose: 1–2 mg | Frequency: Once daily | Notes: Ready-to-use dosing; follow research titration protocol

Cycle Protocol (Investigational)

Initial Phase (1–2 weeks) – Dose: 0.5–1 mg/day | Notes: Assess tolerance and response

Therapeutic Phase (4–8 weeks) – Dose: 1–2 mg/day | Notes: Optimal GH stimulation

Rest Period (2–4 weeks) – Dose: None | Notes: Allows system to reset before next cycle

Experimental cycles may be repeated 2–3 times per year, depending on research goals.

Supplies Needed:

• Sterile bacteriostatic water
• Sterile syringe
• Alcohol swabs

Steps:

1. Clean vial top with alcohol swab.
2. Add desired volume of bacteriostatic water (e.g., 2 mg peptide + 1 mL water → 2 mg/mL solution).
3. Swirl gently to dissolve; do not shake.
4. Store refrigerated (2–8°C).
5. Use within 2–4 weeks; discard if cloudy or discolored.

Subcutaneous Injection (SC)

1. Select a clean injection site (abdomen, thigh, upper arm).
2. Clean site with alcohol swab.
3. Insert needle at 45° angle.
4. Inject slowly; apply gentle pressure afterward.
5. Rotate injection sites weekly.

Pre-filled Pen Administration

• Follow pen instructions for dose selection and injection.
• Administer once daily, preferably at night.
• Rotate injection sites to avoid tissue irritation.

Storage Information

Lyophilized Powder – Storage: Cool, dry place | Shelf Life: Up to 12 months

Reconstituted Solution – Storage: Refrigerate 2–8°C | Shelf Life: 2–4 weeks

Pre-filled Pens – Storage: Refrigerate 2–8°C | Shelf Life: 1–2 months after first use

Discard solution if cloudy, discolored, or contains particulates.

• Not recommended for pregnant or breastfeeding women
• Avoid if allergic to GH analogs or peptide components
• Mild side effects: injection site redness, mild edema, or transient headache
• Discontinue if severe adverse reactions occur
• Keep out of reach of children

Human clinical data exist for metabolic conditions, but research protocols may differ. All investigational use should follow safety monitoring.

Dosing ScheduleWeek 1–2 – Dose: 0.5–1 mg SC/day | Notes: Initial tolerance phase

Week 3–8 – Dose: 1–2 mg SC/day | Notes: Therapeutic phase

Week 9+ – Dose: Rest 2–4 weeks | Notes: Reset before next cycle

• Diagrams of SC injection sites (abdomen, thigh, upper arm)
• Step-by-step reconstitution guide
• Pre-filled pen usage instructions
• Safety icons for handling, storage, and injections